These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 15234426

  • 21. Blood pressure, antihypertensive treatment, and graft survival in kidney transplant patients.
    Hillebrand U, Suwelack BM, Loley K, Lang D, Reuter S, Amler S, Pavenstädt H, Hausberg M, Büssemaker E.
    Transpl Int; 2009 Nov; 22(11):1073-80. PubMed ID: 19624495
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Atrial fibrillation at baseline and during follow-up in ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial).
    Haywood LJ, Ford CE, Crow RS, Davis BR, Massie BM, Einhorn PT, Williard A, ALLHAT Collaborative Research Group.
    J Am Coll Cardiol; 2009 Nov 24; 54(22):2023-31. PubMed ID: 19926008
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Drug Insight: angiotensin-converting-enzyme inhibitors and atrial fibrillation--indications and contraindications.
    Lévy S.
    Nat Clin Pract Cardiovasc Med; 2006 Apr 24; 3(4):220-5. PubMed ID: 16568131
    [Abstract] [Full Text] [Related]

  • 27. Antihypertensives and myocardial infarction risk: the modifying effect of history of drug use.
    Bourgault C, Elstein E, Baltzan MA, Le Lorier J, Suissa S.
    Pharmacoepidemiol Drug Saf; 2001 Apr 24; 10(4):287-94. PubMed ID: 11760488
    [Abstract] [Full Text] [Related]

  • 28. Atenolol as initial antihypertensive therapy: an observational study comparing first-line agents.
    Blackburn DF, Lamb DA, Eurich DT, Johnson JA, Wilson TW, Dobson RT, Blackburn JL.
    J Hypertens; 2007 Jul 24; 25(7):1499-505. PubMed ID: 17563574
    [Abstract] [Full Text] [Related]

  • 29. Coronary surgery in patients with preexisting chronic atrial fibrillation: early and midterm clinical outcome.
    Rogers CA, Angelini GD, Culliford LA, Capoun R, Ascione R.
    Ann Thorac Surg; 2006 May 24; 81(5):1676-82. PubMed ID: 16631655
    [Abstract] [Full Text] [Related]

  • 30. Inefficiency of renin-angiotensin inhibitors in preventing atrial fibrillation in patients with a normal heart.
    Fazio G, Pizzuto C, Sutera L, Guttilla D, Di Gesaro G, Cascio C, Novo G, Assennato P, Novo S.
    Minerva Cardioangiol; 2007 Jun 24; 55(3):311-5. PubMed ID: 17534249
    [Abstract] [Full Text] [Related]

  • 31. Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation: The Losartan Intervention For End Point Reduction in Hypertension (LIFE) study.
    Wachtell K, Hornestam B, Lehto M, Slotwiner DJ, Gerdts E, Olsen MH, Aurup P, Dahlöf B, Ibsen H, Julius S, Kjeldsen SE, Lindholm LH, Nieminen MS, Rokkedal J, Devereux RB.
    J Am Coll Cardiol; 2005 Mar 01; 45(5):705-11. PubMed ID: 15734614
    [Abstract] [Full Text] [Related]

  • 32. The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3-year, randomized, multicenter, double-blind, placebo-controlled study.
    Esnault VL, Brown EA, Apetrei E, Bagon J, Calvo C, DeChatel R, Holdaas H, Krcmery S, Kobalava Z, Amlodipine Versus Enalapril in Renal failure (AVER) Study Group.
    Clin Ther; 2008 Mar 01; 30(3):482-98. PubMed ID: 18405787
    [Abstract] [Full Text] [Related]

  • 33. Fasting glucose levels and incident diabetes mellitus in older nondiabetic adults randomized to receive 3 different classes of antihypertensive treatment: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Barzilay JI, Davis BR, Cutler JA, Pressel SL, Whelton PK, Basile J, Margolis KL, Ong ST, Sadler LS, Summerson J, ALLHAT Collaborative Research Group.
    Arch Intern Med; 2006 Nov 13; 166(20):2191-201. PubMed ID: 17101936
    [Abstract] [Full Text] [Related]

  • 34. Pulse pressure monitoring of open antihypertensive therapy.
    Safar ME, Vaisse B, Blacher J, Rudnichi A, Mourad JJ.
    Am J Hypertens; 2004 Dec 13; 17(12 Pt 1):1088-94. PubMed ID: 15607613
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Does treatment with ACE inhibitors or angiotensin II receptor antagonists prevent atrial fibrillation after dual chamber pacemaker implantation?
    Williams SG, Connelly DT, Jackson M, Bennett A, Albouaini K, Todd DM.
    Europace; 2005 Nov 13; 7(6):554-9. PubMed ID: 16216757
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Prevention of recurrent lone atrial fibrillation by the angiotensin-II converting enzyme inhibitor ramipril in normotensive patients.
    Belluzzi F, Sernesi L, Preti P, Salinaro F, Fonte ML, Perlini S.
    J Am Coll Cardiol; 2009 Jan 06; 53(1):24-9. PubMed ID: 19118720
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.